NCT06469606 Study on Female Patients' Mammographic Texture Features
| NCT ID | NCT06469606 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tampere University Hospital |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-06-17 |
| Primary Completion | 2035-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-06-17 with a primary completion date of 2035-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Mammography is the most common method for breast imaging, and it provides information for model building and analysis. Radiomics applied to mammography has the potential to revolutionize clinical decision-making by providing valuable insights into risk assessment and disease detection. Despite this, the influence of imaging parameters and clinical and biological factors on radiological texture features remains poorly understood. There is a pressing need to overcome the obstacle of system-inherent effects on mammographic images to facilitate the translation of radiological texture features into routine clinical practice by enabling reliable and robust AI-based or AI-aided decision-making. Furthermore, understanding the relationship between imaging parameters, textural features, and clinical and biological information supports the clinical use of AI. The objective of this study is to evaluate AI methods for clinical practice and to study how it relates to clinical factors and biological features.
Eligibility Criteria
Inclusion Criteria: * Candidate is a biological female aged 18 years or above; * Candidate is willing and able to give informed consent and gives their written consent for the participation in the study; * There is a clinical indication for a uni- or bilateral mastectomy Exclusion Criteria: * Candidate lacks the capacity to provide informed consent; * Candidate has breast implants
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06469606 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06469606 currently recruiting?
Yes, NCT06469606 is actively recruiting participants. Contact the research team at otso.arponen@tuni.fi for enrollment information.
Where is the NCT06469606 trial being conducted?
This trial is being conducted at Tampere, Finland.
Who is sponsoring the NCT06469606 clinical trial?
NCT06469606 is sponsored by Tampere University Hospital. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.